Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia
- PMID: 23391444
- DOI: 10.1016/j.jconrel.2013.01.026
Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia
Abstract
Accumulation of nanoparticles in solid tumors depends on their extravasation. However, vascular permeability is very heterogeneous within a tumor and among different tumor types, hampering efficient delivery. Local hyperthermia at a tumor can improve nanoparticle delivery by increasing tumor vasculature permeability, perfusion and interstitial fluid flow. The aim of this study is to investigate hyperthermia conditions required to improve tumor vasculature permeability, subsequent liposome extravasation and interstitial penetration in 4 tumor models. Tumors are implanted in dorsal skin flap window chambers and observed for liposome (~85 nm) accumulation by intravital confocal microscopy. Local hyperthermia at 41°C for 30 min initiates liposome extravasation through permeable tumor vasculature in all 4 tumor models. A further increase in nanoparticle extravasation occurs while continuing heating to 1h, which is a clinically relevant duration. After hyperthermia, the tumor vasculature remains permeable for 8h. We visualize gaps in the endothelial lining of up to 10 μm induced by HT. Liposomes extravasate through these gaps and penetrate into the interstitial space to at least 27.5 μm in radius from the vessel walls. Whole body optical imaging confirms HT induced extravasation while liposome extravasation was absent at normothermia. In conclusion, a thermal dose of 41°C for 1h is effective to induce long-lasting permeable tumor vasculature for liposome extravasation and interstitial penetration. These findings hold promise for improved intratumoral drug delivery upon application of local mild hyperthermia prior to administration of nanoparticle-based drug delivery systems.
Copyright © 2013 Elsevier B.V. All rights reserved.
Comment in
-
Improved tumor targeting by mild hyperthermia.J Control Release. 2013 Apr 28;167(2):220. doi: 10.1016/j.jconrel.2013.03.002. J Control Release. 2013. PMID: 23534993 No abstract available.
Similar articles
-
Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size.Cancer Res. 2000 Aug 15;60(16):4440-5. Cancer Res. 2000. PMID: 10969790
-
Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.Cancer Res. 2001 Apr 1;61(7):3027-32. Cancer Res. 2001. PMID: 11306483
-
Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.J Control Release. 2013 Jun 10;168(2):142-50. doi: 10.1016/j.jconrel.2013.03.011. Epub 2013 Mar 21. J Control Release. 2013. PMID: 23524188
-
A moderate thermal dose is sufficient for effective free and TSL based thermochemotherapy.Adv Drug Deliv Rev. 2020;163-164:145-156. doi: 10.1016/j.addr.2020.03.006. Epub 2020 Apr 2. Adv Drug Deliv Rev. 2020. PMID: 32247801 Review.
-
Ultrasound-induced cell permeabilisation and hyperthermia: strategies for local delivery of compounds with intracellular mode of action.Int J Hyperthermia. 2012;28(4):311-9. doi: 10.3109/02656736.2012.664307. Int J Hyperthermia. 2012. PMID: 22621733 Review.
Cited by
-
Hyperthermia and Temperature-Sensitive Nanomaterials for Spatiotemporal Drug Delivery to Solid Tumors.Pharmaceutics. 2020 Oct 22;12(11):1007. doi: 10.3390/pharmaceutics12111007. Pharmaceutics. 2020. PMID: 33105816 Free PMC article. Review.
-
Application of pharmacokinetic and pharmacodynamic analysis to the development of liposomal formulations for oncology.Pharmaceutics. 2014 Mar 18;6(1):137-74. doi: 10.3390/pharmaceutics6010137. Pharmaceutics. 2014. PMID: 24647104 Free PMC article.
-
A Review of In Vitro Instrumentation Platforms for Evaluating Thermal Therapies in Experimental Cell Culture Models.Crit Rev Biomed Eng. 2022;50(2):39-67. doi: 10.1615/CritRevBiomedEng.2022043455. Crit Rev Biomed Eng. 2022. PMID: 36374822 Free PMC article. Review.
-
Liposomal Drug Delivery Systems for Cancer Therapy: The Rotterdam Experience.Pharmaceutics. 2022 Oct 11;14(10):2165. doi: 10.3390/pharmaceutics14102165. Pharmaceutics. 2022. PMID: 36297598 Free PMC article. Review.
-
Mild hyperthermia influence on Herceptin(®) properties.Radiol Oncol. 2015 Mar 3;49(1):41-9. doi: 10.2478/raon-2014-0045. eCollection 2015 Mar. Radiol Oncol. 2015. PMID: 25810700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical